文献速递妇科生殖医学

NR5A2通过NF-κB通路加剧多内分泌代谢性卵巢综合征炎症与细胞增殖

NR5A2 increases inflammation and cell proliferation by regulating the nuclear factor κB pathway in polyendocrine metabolic ovarian syndrome.
PubMed 文献 · Reprod Biomed Online · 2026-06-11

研究探讨NR5A2在多内分泌代谢性卵巢综合征(PMOS)颗粒细胞失调中的作用及机制。比较PMOS患者与非PMOS患者人颗粒细胞中NR5A2表达,并在KGN细胞系进行体外实验。结果提示上调的NR5A2可能通过增强NF-κB p65活性促进慢性炎症和颗粒细胞异常增殖。

要点

  • PMOS患者颗粒细胞中NR5A2表达上调,与炎症及增殖异常相关
  • NR5A2作为NF-κB p65共激活因子,增强其磷酸化与核定位
  • NR5A2通过NF-κB通路调控CCND1和IL-1β正反馈环路

核心结论

  • 上调的NR5A2可能通过增加NF-κB p65活性促进颗粒细胞慢性炎症和异常增殖,是改善PMOS卵巢功能障碍的潜在治疗靶点。

研究设计与样本

  • 研究比较PMOS患者与非PMOS患者来源的人颗粒细胞中NR5A2及相关基因mRNA表达,并使用KGN人颗粒细胞样细胞系进行体外实验。

主要发现

  • NR5A2过表达促进KGN细胞增殖并诱导G1到S期转换,至少部分通过上调cyclin D1(CCND1)表达实现。
  • NR5A2作为NF-κB p65(RelA)共激活因子,增加其磷酸化和核定位,从而通过转录调控增加CCND1表达。
  • NR5A2通过NF-κB p65信号通路调控IL-1β正自我调节环路。

临床怎么用

  • NR5A2及其调控的NF-κB通路可作为PMOS相关卵巢功能障碍的潜在干预靶点,但尚需进一步临床验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Does NR5A2 (nuclear receptor subfamily 5 group A member 2) play a role in the dysregulation of granulosa cells in polyendocrine metabolic ovarian syndrome (PMOS), which is a common endocrine disorder and a leading cause of anovulatory infertility, and what are its underlying regulatory mechanisms? DESIGN: The mRNA expression levels of NR5A2 and related genes were assessed in human granulosa cells (HGCs) isolated from patients with or without PMOS. To investigate the effects of NR5A2 on inflammation and proliferation of granulosa cells, as well as the underlying molecular mechanisms, in-vitro experiments were conducted using the KGN human granulosa-like cell line. RESULTS: Overexpression of NR5A2 promoted cell proliferation and induced G1-to-S phase transition in KGN cells, at least in part by upregulating cyclin D1 (CCND1) expression. NR5A2 acted as a co-activator of NF-κB p65 (also known as RelA) by increasing its phosphorylation and nuclear localization, thereby increasing CCND1 expression through transcriptional regulation. Furthermore, NR5A2 regulated the IL-1β positive self-regulatory loop via the NF-κB p65 signalling pathway. CONCLUSIONS: Up-regulated NR5A2 may contribute to chronic inflammation and aberrant proliferation of granulosa cells by increasing NF-κB p65 activity. These findings highlight NR5A2 as a potential therapeutic target for ameliorating ovarian dysfunction in patients with PMOS.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Zhou R, Wang Z, Dong M, et al. NR5A2 increases inflammation and cell proliferation by regulating the nuclear factor κB pathway in polyendocrine metabolic ovarian syndrome. Reprod Biomed Online. 2026. PMID: 42542018. doi:10.1016/j.rbmo.2026.105821

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。